Scapa Group plc provided revenue guidance for the six months ended 30 September 2017. Group revenue, trading profits and margins are all ahead of last year. Healthcare sales grew 7.9%, or 2.1% at constant exchange rates, with improvement in both trading profit and margins. The company remain confident of strong progress for the fiscal year 2018, and anticipate the profit for the fiscal year 2018 will be ahead of current expectations.